Work

Serum neurofilament light levels in natalizumab-treated patients with multiple sclerosis who switch to extended interval dosing from every-4-week dosing in real-world clinical practice

Year: 2022

Type: article

Study design: Observational Study

Source: Multiple Sclerosis Journal

DOI: 10.1177/13524585221130949

Authors: John Foley, Kuangnan Xiong, Tammy Hoyt, Carol M Singh, Evan Riddle, Carl de Moor, Tatiana Plavina, Nolan Campbell

Institutions: Rocky Mountain Multiple Sclerosis Clinic, Biogen (United States)

Language: English

Topic: Multiple Sclerosis Research Studies

Subfield: Pathology and Forensic Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funder: Biogen

OpenAlex ID: W4309096426

FWCI: 0.85

Cites: 39

Cited by: 5

Related to: 10